2015 PIP Partnership Contribution (PC) Collection Results ...

2015 PIP Partnership Contribution (PC) Collection Results as of 1 April 2016

As of 1 April 2016, WHO received USD 18,813,378 from 23 contributors. This process started with the publication of the 2015 PC Questionnaire, used by WHO to identify influenza vaccine, diagnostic and pharmaceutical manufacturers using GISRS.

Based on the preliminary results of the 2015 Questionnaire the following 39 entities were requested to contribute to the 2015 Partnership Contribution as provided under section 6.14.3 of the PIP Framework.

In accordance with the process detailed in Section IV of the document "Distribution of Partnership Contribution among companies"1 each entity identified as a Contributor calculated its four-year average annual influenza product sales2 and informed WHO of its Band Number. Subsequently, WHO applied the formula found in Section III of the same document3 and sent each entity an invoice for the corresponding amount. The results are found in the Tables 1 and 2 below. Table 3 lists entities that have been removed from the Contributor's list as well as the reasons for their removal. Lastly, Table 4 provides a summary of amounts due by sales' band.

Experiences in collecting contributions have highlighted some challenges faced by companies, notably the ability to pay contributions in full, in a single payment. In accordance with guidance provided by the Advisory Group, the PIP Secretariat gave companies facing such issues the possibility of paying in installments.

Some payments remain in progress. Consistent with past practice, the PIP Secretariat will continue to seek payment of 2015 contributions until all are received.

Entities identified as 2015 PC Contributors

Band Number

8

10 14 15

16

17

20 21

Table 1: 2015 Contributions Received

Contributor

F.Hoffman La Roche Ltd. GlaxoSmithKline NVS Influenza Vaccines BioCSL Pty Ltd The Chemo-Sero-Therapeutic Research Institute (Kaketsuken) Denka Seiken Co., Ltd The Research Foundation for Microbial Diseases of Osaka University (BIKEN) Green Cross Corp. Kitasato Daiichi Sankyo Vaccine Co. Ltd. Becton, Dickinson and Company CNBG - Shanghai Institute of Biological Products Co., Ltd.

1 See: 2 Id. at page 4, section III B). 3 Id. at page 6.

Status

Paid Paid Paid Paid Paid Paid Paid Paid Paid Paid Paid

1

Band Number

22 23

Table 1: 2015 Contributions Received

Contributor

Fluart Innovative Vaccines Ltd CNBG - Changchun Institute of Biological Products Co. Ltd Focus Diagnostics Inc. Qiagen Cepheid Nanotherapeutics Quidel Response Biomedical Corp. Serum Institute of India Ltd. Takeda Pharmaceuticals Int. The Government Pharmaceutical Organization (GPO) The Company for vaccine and biological production No.1 (VABIOTECH)

Status

Paid Paid Paid Paid Paid Paid Paid Paid Paid Paid Paid Paid

Band Number

7 13 16

21

22

23

Table 2: 2015 Contributions in Progress

Contributor

Sanofi Pasteur MedImmune (AstraZeneca) Alere Inc. Adimmune Corporation Hualan Biological Bacterin Co.Ltd Sinovac Biotech Co. Ltd CNBG- Beijing Tiantan Institute of Biological Products Co. Ltd Saint-Petersburg Scientific Research Institute of Vaccines and Sera Fast Track Diagnostics Institute of Vaccine and Medical Biologicals IVAC Lovelace Respiratory Research Institute Nanosphere Inc. NPO Petrovax Pharm LLC Princeton BioMeditech Corporation Sino Biological Inc. Zydus Cadila Healthcare Ltd.

Status

In Progress In Progress In Progress In Progress In Progress In Progress In Progress In Progress In Progress In Progress In Progress In Progress In Progress In Progress In Progress In Progress

2

Table 3: Entities removed from the 2015 Contributor's list

Band Number

23

Entity

Institute of Virology, Vaccines and Sera Torlak Paxvax

Research Institute for Biological Safety Problems (RIBSP)

Explanation

Incorrectly answered the questionnaire: Influenza product pending license Incorrectly answered the questionnaire: Influenza product pending license Incorrectly answered the questionnaire: Pending influenza production facility

Table 4: 2015 Sales Bands

Band Number

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Average annual influenza product sales

(in USD millions) > 3500 ? 4000 > 3000 ? 3500 > 2500 ? 3000 > 2100 ? 2500 > 1800 ? 2100 > 1500 ? 1800 > 1200 ? 1500 > 1000 ? 1200 > 800 ? 1000 > 600 ? 800 > 400 ? 600 > 300 ? 400 > 200 ? 300 > 150 ? 200 > 100 ? 150 > 70 ? 100 > 50 ? 70 > 40 ? 50 > 30 ? 40 > 20 ? 30 > 10 ? 20 > 1 ? 10 0 ? 1

Weight

750 650 550 460 390 330 270 220 180 140 100

70 50 35 25 17 12

9 7 5 3 1.1 0.1

Band Amount (USD)

N/A N/A N/A N/A N/A N/A 7,123,339 5,804,202 N/A 3,693,583 N/A N/A 1,319,137 923,396 659,568 448,507 316,593 N/A N/A 131,914 79,148 29,021 2,638

3

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download